Showing results (11-20 of 385) with videos related to
Sort By:
Pageof 39
The American Review of Respiratory Disease|April 1, 1991
Critical analysis of neoadjuvant therapy for Stage IIIa non-small cell lung cancer [corrected]J R Murren, A C Buzaid, W N HaitJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
Dose-escalation and pharmacodynamic study of topotecan in combination with cyclophosphamide in patients with refractory cancerJ R Murren, S Anderson, J Fedele, et al.The Journal of Clinical Investigation|May 1, 1993
Sensitivity of K562 human chronic myelogenous leukemia blast cells transfected with a human multidrug resistance cDNA to cytotoxic drugs and differentiating agentsW N Hait, S Choudhury, S Srimatkandada, et al.Cancer Research|May 15, 1992
Development and characterization of a WEHI-3B D+ monomyelocytic leukemia cell line resistant to novobiocin and cross-resistant to other topoisomerase II-targeted drugsG Rappa, A Lorico, A C SartorelliCancer Research|October 15, 1990
Induction of the differentiation of WEHI-3B D+ monomyelocytic leukemia cells by inhibitors of topoisomerase IIG Rappa, A Lorico, A C SartorelliCancer Research|November 15, 1993
Reversal of etoposide resistance in non-P-glycoprotein expressing multidrug resistant tumor cell lines by novobiocinG Rappa, A Lorico, A C SartorelliInternational Journal of Cancer|July 9, 1992
Potentiation by novobiocin of the cytotoxic activity of etoposide (VP-16) and teniposide (VM-26)G Rappa, A Lorico, A C SartorelliInternational Journal of Cancer|December 2, 1992
Novobiocin-induced accumulation of etoposide (VP-16) in WEHI-3B D+ leukemia cellsA Lorico, G Rappa, A C SartorelliOncology (Williston Park, N.Y.)|February 28, 2001
Rationale and dose-finding studies of the combination of irinotecan and a taxane on a weekly scheduleJ R Murren, K Blum, M Gallipoli, et al.Archives of Internal Medicine|August 1, 1987
Early predictors of in-hospital mortality for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndromeC P Kales, J R Murren, R A Torres, et al.Pageof 39